Search research articles
Contact Us
Filters
Showing results (131-140 of 150) with videos related to
Page
of 15
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
Synonymous substitution rate slowdown preceding the emergence of SARS-CoV-2 variants and during persistent infections
Jennifer L Havens, Karthik Gangavarapu, Jade C Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 24, 2012
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial
Peter L Havens, Charles B Stephensen, Rohan Hazra, et al.
The Pediatric Infectious Disease Journal
|
May 15, 2021
Blastomycosis in 64 Wisconsin Children: Unanticipated Infection Risk and Severity in Urban Residents
Jaimee M Hall, Peter L Havens, Errin A Mitchell, et al.
Biorxiv : the Preprint Server for Biology
|
July 28, 2023
The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2
Jonathan E Pekar, Spyros Lytras, Mahan Ghafari, et al.
Archives of Pediatrics & Adolescent Medicine
|
July 26, 2011
Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome
Christina A Hickey, T James Beattie, Jennifer Cowieson, et al.
Cell
|
May 8, 2025
The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2
Jonathan E Pekar, Spyros Lytras, Mahan Ghafari, et al.
Antiviral Therapy
|
February 19, 2014
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate
Peter L Havens, Rohan Hazra, Charles B Stephensen, et al.
Antimicrobial Agents and Chemotherapy
|
September 5, 2013
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?
Peter L Havens, Jennifer J Kiser, Charles B Stephensen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial
Peter L Havens, Charles B Stephensen, Marta D Van Loan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 26, 2016
Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis
Peter L Havens, Charles B Stephensen, Marta D Van Loan, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 150) with videos related to
Sort By:
Page
of 15
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
Synonymous substitution rate slowdown preceding the emergence of SARS-CoV-2 variants and during persistent infections
Jennifer L Havens, Karthik Gangavarapu, Jade C Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 24, 2012
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial
Peter L Havens, Charles B Stephensen, Rohan Hazra, et al.
The Pediatric Infectious Disease Journal
|
May 15, 2021
Blastomycosis in 64 Wisconsin Children: Unanticipated Infection Risk and Severity in Urban Residents
Jaimee M Hall, Peter L Havens, Errin A Mitchell, et al.
Biorxiv : the Preprint Server for Biology
|
July 28, 2023
The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2
Jonathan E Pekar, Spyros Lytras, Mahan Ghafari, et al.
Archives of Pediatrics & Adolescent Medicine
|
July 26, 2011
Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome
Christina A Hickey, T James Beattie, Jennifer Cowieson, et al.
Cell
|
May 8, 2025
The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2
Jonathan E Pekar, Spyros Lytras, Mahan Ghafari, et al.
Antiviral Therapy
|
February 19, 2014
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate
Peter L Havens, Rohan Hazra, Charles B Stephensen, et al.
Antimicrobial Agents and Chemotherapy
|
September 5, 2013
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?
Peter L Havens, Jennifer J Kiser, Charles B Stephensen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial
Peter L Havens, Charles B Stephensen, Marta D Van Loan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 26, 2016
Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis
Peter L Havens, Charles B Stephensen, Marta D Van Loan, et al.
Page
of 15